Market Cap 21.91B
Revenue (ttm) 2.98B
Net Income (ttm) -719.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.18%
Debt to Equity Ratio 0.01
Volume 1,548,700
Avg Vol 950,752
Day's Range N/A - N/A
Shares Out 225.18M
Stochastic %K 9%
Beta 1.30
Analysts Strong Sell
Price Target $137.42

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 6131 9084
Fax: 49 6131 9084
Address:
An der Goldgrube 12, Mainz, Germany
taxplanr
taxplanr Dec. 10 at 3:07 PM
Another success story against Lung cancer with Ivermectin $BNTX $GSK https://makisw.substack.com/p/ivermectin-fenbendazole-artemisia?utm_source=post-email-title&publication_id=1385328&post_id=181222821&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Dec. 10 at 2:50 PM
Dims are going to out their RINO'S with this move $PFE $MRNA $BNTX https://www.foxnews.com/politics/house-democrat-introduces-impeachment-articles-against-rfk-jr
0 · Reply
Robert321
Robert321 Dec. 10 at 12:29 PM
$BNTX Buyrating: https://seekingalpha.com/article/4851780-biontech-strong-buy-after-part-1-success-of-next-gen-anti-ctla-4-gotistobart
0 · Reply
AlertsAndNews
AlertsAndNews Dec. 10 at 4:13 AM
$MRNA $PFE $BNTX FDA Probes Potential Links Between Covid-19 Vaccines and Adult Deaths – Bloomberg The FDA has opened an investigation into whether Covid-19 vaccines may be connected to deaths in adults, federal health officials said. An HHS spokesperson noted the agency is reviewing cases across multiple age groups as part of a broader safety assessment.
0 · Reply
taxplanr
taxplanr Dec. 10 at 1:16 AM
$BNTX $MRNA $PFE help get the child killer revoked https://childrenshealthdefense.org/defender/chd-asks-fda-to-revoke-covid-vaccine-licenses-petition/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20251209
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 9 at 10:06 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BNTX $95.00 Put · DEC 19, 2025 Exp Entry Price: $2.25 - $2.35 Exit Price Target: $4.79 Profit Margin: +113% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
topstockalerts
topstockalerts Dec. 9 at 8:08 PM
According to a Bloomberg report, the U.S. Food and Drug Administration is conducting an investigation into potential adult deaths associated with Covid-19 vaccines. The scope of the inquiry is broader than previously understood, as it now includes cases across both adult and pediatric age groups. An FDA spokesperson told Bloomberg on Tuesday that the agency is performing a comprehensive, multi-division review of deaths that could be linked to Covid vaccination. Earlier reports had indicated the evaluation was focused only on pediatric cases, but the expanded probe shows a wider internal effort. The development follows a leaked internal memo from last month in which Vinay Prasad, the FDA’s top vaccine regulator, stated that a review had identified 10 child deaths occurring after Covid vaccination. $MRNA $PFE $BNTX
2 · Reply
Robert321
Robert321 Dec. 9 at 7:39 PM
$BNTX https://www.thepharmaletter.com/pharmaceutical/gotistobart-phase-iii-data-a-potentially-best-in-class-ctla-4-mab-in-squamous-nsclc-and-beyond !!!Best in Class CLTA-4!!!
0 · Reply
taxplanr
taxplanr Dec. 9 at 6:46 PM
FDA says COVID jabs kill children $BNTX $MRNA $PFE https://m.youtube.com/watch?v=iY7SMvxDrNM&t=13s&pp=2AENkAIB0gcJCR4Bo7VqN5tD
1 · Reply
BrendaGarrett356
BrendaGarrett356 Dec. 9 at 5:24 PM
$BNTX oncology pipeline progress bringing fresh speculative flow into biotech momentum
1 · Reply
Latest News on BNTX
BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025, 8:17 AM EST - 27 days ago

BioNTech says collaboration with Pfizer remains unchanged

PFE


BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 12:46 PM EST - 5 weeks ago

BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript


BioNTech to Host Innovation Series R&D Day on November 11, 2025

Oct 28, 2025, 7:45 AM EDT - 6 weeks ago

BioNTech to Host Innovation Series R&D Day on November 11, 2025


Moderna Vs BioNTech: Who's Winning The Post-COVID Race

Oct 18, 2025, 9:30 AM EDT - 7 weeks ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

MRNA


BioNTech SE, InstaDeep Ltd - Special Call

Oct 1, 2025, 6:52 PM EDT - 2 months ago

BioNTech SE, InstaDeep Ltd - Special Call


Why BioNTech Stock Jumped by Nearly 4% on Wednesday

Oct 1, 2025, 6:13 PM EDT - 2 months ago

Why BioNTech Stock Jumped by Nearly 4% on Wednesday


Why BioNTech Stock Bumped Higher Today

Sep 22, 2025, 6:45 PM EDT - 2 months ago

Why BioNTech Stock Bumped Higher Today


Why BioNTech Stock Sank by More Than 7% Today

Sep 12, 2025, 6:19 PM EDT - 3 months ago

Why BioNTech Stock Sank by More Than 7% Today


Why BioNTech Stock Crushed the Market Today

Sep 5, 2025, 4:41 PM EDT - 3 months ago

Why BioNTech Stock Crushed the Market Today


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 3 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY DHR GRAL ILMN IONS MRNA RGEN


BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:56 PM EDT - 4 months ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript


BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 7:01 AM EDT - 4 months ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.


BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:52 AM EDT - 4 months ago

BioNTech's Q2 revenues double on higher COVID vaccine sales


taxplanr
taxplanr Dec. 10 at 3:07 PM
Another success story against Lung cancer with Ivermectin $BNTX $GSK https://makisw.substack.com/p/ivermectin-fenbendazole-artemisia?utm_source=post-email-title&publication_id=1385328&post_id=181222821&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Dec. 10 at 2:50 PM
Dims are going to out their RINO'S with this move $PFE $MRNA $BNTX https://www.foxnews.com/politics/house-democrat-introduces-impeachment-articles-against-rfk-jr
0 · Reply
Robert321
Robert321 Dec. 10 at 12:29 PM
$BNTX Buyrating: https://seekingalpha.com/article/4851780-biontech-strong-buy-after-part-1-success-of-next-gen-anti-ctla-4-gotistobart
0 · Reply
AlertsAndNews
AlertsAndNews Dec. 10 at 4:13 AM
$MRNA $PFE $BNTX FDA Probes Potential Links Between Covid-19 Vaccines and Adult Deaths – Bloomberg The FDA has opened an investigation into whether Covid-19 vaccines may be connected to deaths in adults, federal health officials said. An HHS spokesperson noted the agency is reviewing cases across multiple age groups as part of a broader safety assessment.
0 · Reply
taxplanr
taxplanr Dec. 10 at 1:16 AM
$BNTX $MRNA $PFE help get the child killer revoked https://childrenshealthdefense.org/defender/chd-asks-fda-to-revoke-covid-vaccine-licenses-petition/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20251209
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 9 at 10:06 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BNTX $95.00 Put · DEC 19, 2025 Exp Entry Price: $2.25 - $2.35 Exit Price Target: $4.79 Profit Margin: +113% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
topstockalerts
topstockalerts Dec. 9 at 8:08 PM
According to a Bloomberg report, the U.S. Food and Drug Administration is conducting an investigation into potential adult deaths associated with Covid-19 vaccines. The scope of the inquiry is broader than previously understood, as it now includes cases across both adult and pediatric age groups. An FDA spokesperson told Bloomberg on Tuesday that the agency is performing a comprehensive, multi-division review of deaths that could be linked to Covid vaccination. Earlier reports had indicated the evaluation was focused only on pediatric cases, but the expanded probe shows a wider internal effort. The development follows a leaked internal memo from last month in which Vinay Prasad, the FDA’s top vaccine regulator, stated that a review had identified 10 child deaths occurring after Covid vaccination. $MRNA $PFE $BNTX
2 · Reply
Robert321
Robert321 Dec. 9 at 7:39 PM
$BNTX https://www.thepharmaletter.com/pharmaceutical/gotistobart-phase-iii-data-a-potentially-best-in-class-ctla-4-mab-in-squamous-nsclc-and-beyond !!!Best in Class CLTA-4!!!
0 · Reply
taxplanr
taxplanr Dec. 9 at 6:46 PM
FDA says COVID jabs kill children $BNTX $MRNA $PFE https://m.youtube.com/watch?v=iY7SMvxDrNM&t=13s&pp=2AENkAIB0gcJCR4Bo7VqN5tD
1 · Reply
BrendaGarrett356
BrendaGarrett356 Dec. 9 at 5:24 PM
$BNTX oncology pipeline progress bringing fresh speculative flow into biotech momentum
1 · Reply
10_100_1000
10_100_1000 Dec. 9 at 4:33 PM
$CADL $ILMN $LEGN $BNTX $EXEL IN CASE THESE COMPANIES DON'T KNOW YET AND MIGHT WANT TO BUY LNAI 11/5/25 Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy https://finviz.com/news/218876/lunai-bioworks-achieves-complete-regression-of-both-primary-and-metastatic-pancreatic-tumors-in-preclinical-humanized-models-marking-a-breakthrough-in-allogeneic-cancer-
0 · Reply
taxplanr
taxplanr Dec. 9 at 3:53 PM
$BNTX going with pig pHarma standard grade 3 side effects instead of PEMF zero side effects and increased vitality as with Truvaga Plus from $ECOR Stupid is as stupid does https://onlinelibrary.wiley.com/doi/full/10.1155/2021/9913716
0 · Reply
BullYa
BullYa Dec. 9 at 3:14 PM
$BNTX 📉 $90 ?
0 · Reply
sobelix
sobelix Dec. 9 at 2:53 PM
$BNTX why the drop again? What’s cooking?
1 · Reply
Tennis2012
Tennis2012 Dec. 9 at 1:47 PM
$BNTX very good news last days...must go up.
1 · Reply
Robert321
Robert321 Dec. 9 at 1:24 PM
$BNTX the stupid market didn´t understand the news from Weekend! ...this is a Marketvolume 1,3 - 3 Bill. Dollars per Year! just bought.
1 · Reply
Robert321
Robert321 Dec. 9 at 1:11 PM
$BNTX Next great NEWS! Breast-Cancer with $BMY : https://news.bms.com/news/details/2025/BioNTech-and-Bristol-Myers-Squibb-Present-First-Global-Phase-2-Data-for-PD-L1xVEGF-A-Bispecific-Antibody-Pumitamig-Showing-Encouraging-Efficacy-in-Advanced-Triple-Negative-Breast-Cancer/default.aspx & https://investors.biontech.de/node/17991/html !!
0 · Reply
powellsewa1577
powellsewa1577 Dec. 9 at 1:08 PM
$BNTX BioNTech & $BMY Bristol Myers Squibb – Phase 2 Data for Pumitamig (TNBC) • ORR: 61.5% • DCR: 92.3% • 9-month PFS: 59.3% • Consistent efficacy across PD-L1 levels • Manageable safety; no treatment-related deaths • Supports dose selection for Phase 3 ROSETTA BREAST-01
1 · Reply
Nitroxic73
Nitroxic73 Dec. 8 at 9:29 PM
$BNTX I predict the stock to go vertical by Dec 18. Extremely manipulated to keep price down till CVAC closing.
0 · Reply
BellaC_Trader
BellaC_Trader Dec. 8 at 8:54 PM
$BNTX biotech with headline torque, sentiment can flip fast on pipeline progress
0 · Reply
Khaled43
Khaled43 Dec. 8 at 8:16 PM
$BNTX $ONCO Onco on fire 🔥 soon +10
0 · Reply
BrendaGarrett356
BrendaGarrett356 Dec. 8 at 7:57 PM
$BNTX biotech updates fueling Moderna‑style sector lift
1 · Reply